2025 Financial Calendar
28. February 2025
News Release:
The board has decided that Pharma Equity Group A/S will in future only submit half-yearly financial reports.
This means changes to the previously announced financial calendar for 2025. The current financial calendar for 2025 will look like this:
| Pharma Equity Group 2025 Financial Calendar | |
| March 4 | Deadline for shareholder proposals - Annual General meeting |
| March 20 | Annual Report 2024 |
| April 16 | Annual General Meeting |
| August 14 | Interim Report – for the six-month period ended June 30, 2025 |
Contact person – Investor Relations
On the Company’s website further information and all published announcements can be found.
Inquiries regarding relations with investors and the stock market can be directed to: Thomas Kaas Selsø, CEO, Phone: E-mail: .
About Pharma Equity Group A/S
Pharma Equity Group, a listed company on the Nasdaq Copenhagen stock exchange, is fully dedicated to advancing the medical projects of its subsidiary, Reponex Pharmaceuticals A/S. With an unwavering focus on healthcare, Pharma Equity Group's primary objective is to bring significant value to Reponex Pharmaceuticals' medical projects.
The company is committed to providing extensive support, resources, and expertise to drive the development and success of these projects. As a strategic partner, Pharma Equity Group works closely with Reponex Pharmaceuticals, prioritizing the advancement of innovative medical solutions and breakthrough therapies. This approach ensures a strong commitment to the current medical projects and their development, while – on the longer term – remaining open to new strategic investments for continuous growth.
Attachment
